Intellectus Partners, LLC Pfizer Inc Transaction History

Intellectus Partners, LLC

$383 Million
Q3 2024

A detailed history of Intellectus Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Intellectus Partners, LLC holds 88,751 shares of PFE stock, worth $2.37 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares

88,751

Previous 92,852 4.42%

Holding current value

$2.37 Million

Previous $2.6 Million 1.12%

% of portfolio

0.67%

Previous 0.72%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$27.7 - $31.39 $113,597 - $128,730	-4,101 Reduced 4.42%	88,751 $2.57 Million
Q2 2024 Jul 18, 2024	BUY	$25.26 - $29.6 $67,141 - $78,676	2,658 Added 2.95%	92,852 $2.6 Million
Q1 2024 May 03, 2024	BUY	$25.89 - $29.73 $174,990 - $200,945	6,759 Added 8.1%	90,194 $2.5 Million
Q4 2023 Feb 05, 2024	BUY	$26.13 - $33.94 $218,237 - $283,466	8,352 Added 11.12%	83,435 $2.4 Million
Q3 2023 Oct 25, 2023	SELL	$32.09 - $37.51 $245,263 - $286,688	-7,643 Reduced 9.24%	75,083 $2.49 Million
Q2 2023 Jul 31, 2023	BUY	$36.12 - $41.79 $95,501 - $110,492	2,644 Added 3.3%	82,726 $3.03 Million
Q1 2023 May 04, 2023	BUY	$39.39 - $51.28 $132,074 - $171,941	3,353 Added 4.37%	80,082 $3.27 Million
Q4 2022 Feb 02, 2023	BUY	$41.75 - $54.5 $21,960 - $28,667	526 Added 0.69%	76,729 $3.93 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $2,975 - $3,632	68 Added 0.09%	76,203 $3.34 Million
Q2 2022 Aug 12, 2022	SELL	$46.53 - $55.17 $57,697 - $68,410	-1,240 Reduced 1.6%	76,135 $3.99 Million
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $369,980 - $458,452	-8,087 Reduced 9.46%	77,375 $4.01 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $140,033 - $207,576	-3,389 Reduced 3.81%	85,462 $5.05 Million
Q3 2021 Nov 16, 2021	BUY	$39.25 - $50.42 $837,909 - $1.08 Million	21,348 Added 31.63%	88,851 $3.82 Million
Q2 2021 Aug 13, 2021	BUY	$35.91 - $40.68 $30,487 - $34,537	849 Added 1.27%	67,503 $2.64 Million
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $321,604 - $362,705	9,603 Added 16.83%	66,654 $2.42 Million
Q4 2020 Feb 18, 2021	BUY	$33.47 - $42.56 $1.9 Million - $2.42 Million	56,806 Added 23186.12%	57,051 $2.1 Million
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $1.52 Million - $1.94 Million	-45,522 Reduced 99.46%	245 $2.1 Million
Q3 2020 Nov 16, 2020	BUY	$31.75 - $37.25 $603,123 - $707,601	18,996 Added 70.96%	45,767 $1.68 Million
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $6,927 - $8,404	-230 Reduced 0.85%	26,771 $875,000
Q1 2020 May 14, 2020	SELL	$27.03 - $38.62 $35,139 - $50,206	-1,300 Reduced 4.59%	27,001 $881,000
Q4 2019 Jan 24, 2020	SELL	$32.92 - $37.36 $39,504 - $44,832	-1,200 Reduced 4.07%	28,301 $1.11 Million
Q3 2019 Oct 11, 2019	BUY	$32.49 - $42.13 $1,202 - $1,558	37 Added 0.13%	29,501 $1.06 Million
Q2 2019 Aug 08, 2019	BUY	$36.98 - $41.52 $15,679 - $17,604	424 Added 1.46%	29,464 $1.28 Million
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $52,762 - $57,968	-1,407 Reduced 4.62%	29,040 $1.23 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $422,285 - $481,451	-10,977 Reduced 26.5%	30,447 $1.33 Million
Q3 2018 Nov 15, 2018	BUY	$34.47 - $41.81 $35,814 - $43,440	1,039 Added 2.57%	41,424 $1.83 Million
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $45,347 - $48,344	-1,375 Reduced 3.29%	40,385 $1.47 Million
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $68,095 - $79,000	2,134 Added 5.39%	41,760 $1.48 Million
Q4 2017 Feb 13, 2018	SELL	$33.26 - $35.29 $5,255 - $5,575	-158 Reduced 0.4%	39,626 $1.44 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $17,174 - $18,919	554 Added 1.41%	39,784 $1.42 Million
Q2 2017 Aug 15, 2017	BUY	N/A	39,230	39,230 $1.32 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Intellectus Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intellectus Partners, LLC with notifications on news.

Account

Intellectus Partners, LLC Pfizer Inc Transaction History